Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neurotechnology Innovations Translator
AddedFeb 15, 2024
UpdatedJun 28, 2026
Neurotechnology Innovations Translator

Neurotechnology Innovations Translator

NIT, a neurotech innovator, accelerates development and commercialization of pioneering solutions, reducing risk and capital for investors.

HQ
Columbus, OH, US
Founded
2015
Overview
Compare
Employees

Neurotechnology Innovations Translator (NIT) is a cutting-edge translational center focused on developing and commercializing pioneering neurotechnology solutions to improve patient well-being. Formed in collaboration with over a dozen partners, NIT aims to accelerate the development cycle by reducing time, risk, and capital requirements, leveraging total capital and service commitments of over $160 million.

NIT has made significant strides in the neurotechnology field, bringing together extensive infrastructure and support to foster innovation. The company's collaborative approach with its partners has enabled it to compress development timelines and mitigate investment risks, positioning it as a key player in the neurotechnology market.

Similar Companies

Novela Neurotech logo

Novela Neurotech

novelaneuro.com

NeuroTechnology Investors logo

NeuroTechnology Investors

themdadvantage.com

Neuro42 logo

Neuro42

NeuroX1 logo

NeuroX1

neurox1.com

NeuroTherapia logo

NeuroTherapia

neurotherapia.com

AivoCode logo

AivoCode

aivocode.com

Neuraly logo

Neuraly

neuralymed.com

Precision Neuroscience logo

Precision Neuroscience

precisionneuro.io

Neuralink logo

Neuralink

neuralink.com

Attune Neurosciences logo

Attune Neurosciences

attuneneuro.com

NeuroInitiative logo

NeuroInitiative

neuromore logo

neuromore

neuromore.com

NeuroCytonix logo

NeuroCytonix

neurocytonix.com

NeuroBionics logo

NeuroBionics

Metabrain logo

Metabrain

Neurotechnology Innovations Translator - Quick Facts

Who are Neurotechnology Innovations Translator's competitors?

Companies similar to Neurotechnology Innovations Translator include Novela Neurotech, NeuroTechnology Investors, Neuro42 and NeuroX1.

When was Neurotechnology Innovations Translator founded?

Neurotechnology Innovations Translator was founded in 2015.

Where is Neurotechnology Innovations Translator's headquarters located?

Neurotechnology Innovations Translator's headquarters is located in Columbus, OH, US.

How many employees does Neurotechnology Innovations Translator have?

Neurotechnology Innovations Translator has 2 employees as of Feb 4, 2024.

Neurotechnology Innovations Translator - Classification

Industry
  • Professional Service Companies
Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Customer
  • Enterprise
Main Product
  • Neurotechnology Solutions
Tags
  • Biotech
  • Consulting
  • Healthtech